AstrazenecaAZN
13F holders, Q1 2025 (March 31)4holders +1
0new positions
0sold out
$146.84avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, up 1 from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Boston Common Asset Management, LLC ($27.0M), FNY Investment Advisers, LLC ($2.3M) and SWP Investment Management LLC ($1.9M).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 30,948 shares sold, net −30,948 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Boston Common Asset Management, LLC | 0.82% | Reduce -14.2% | 185,930 | $27.0M |
| FNY Investment Advisers, LLC | 1.40% | No change | 200 | $2.3M |
| SWP Investment Management LLC | 2.37% | — | 25,824 | $1.9M |
| Raffa Wealth Management, LLC | 0.01% | Reduce -18.9% | 441 | $32K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.